Skip to main content
Top
Published in: Journal of Cancer Survivorship 4/2016

01-08-2016

Cancer and frailty in older adults: a nested case-control study of the Mexican Health and Aging Study

Authors: Mario Ulises Pérez-Zepeda, Eduardo Cárdenas-Cárdenas, Matteo Cesari, Ana Patricia Navarrete-Reyes, Luis Miguel Gutiérrez-Robledo

Published in: Journal of Cancer Survivorship | Issue 4/2016

Login to get access

Abstract

Purpose

Understanding how the convergence between chronic and complex diseases—such as cancer—and emerging conditions of older adults—such as frailty—takes place would help in halting the path that leads to disability in this age group. The objective of this manuscript is to describe the association between a past medical history of cancer and frailty in Mexican older adults.

Methods

This is a nested in cohort case-control study of the Mexican Health and Aging Study. Frailty was categorized by developing a 55-item frailty index that was also used to define cases in two ways: incident frailty (incident >0.25 frailty index score) and worsening frailty (negative residuals from a regression between 2001 and 2012 frailty index scores). Exposition was defined as self-report of cancer between 2001 and 2012. Older adults with a cancer history were further divided into recently diagnosed (<10 years) and remotely diagnosed (>10 years from the initial diagnosis). Odds ratios were estimated by fitting a logistic regression adjusted for confounding variables.

Results

Out of a total of 8022 older adults with a mean age of 70.6 years, the prevalence of a past medical history of cancer was 3.6 % (n = 288). Among these participants, 45.1 % had been diagnosed with cancer more than 10 years previously. A higher risk of incident frailty compared to controls [odds ratio (OR) 1.53 (95 % confidence interval (CI) 1.04–2.26, p = 0.03); adjusted model OR 1.74 (95 % CI 1.15–2.61, p = 0.008)] was found in the group with a recent cancer diagnosis. Also, an inverse association between a remote cancer diagnosis and worsening frailty was found [OR = 0.56 (95 % CI 0.39–0.8), p = 0.002; adjusted model OR 0.61 (95 % CI 0.38–0.99, p = 0.046)].

Conclusions

Cancer is associated with a higher frailty index, with a potential relevant role of the time that has elapsed since the cancer diagnosis.

Implications for cancer survivors

Cancer survivors may be more likely to develop frailty or worsening of the health status at an older age. This relationship seems especially evident among individuals with a recent oncological diagnosis. Health professionals in charge of older adult care should be aware of this association in order to improve outcomes of older adults who survived cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al. Cancer incidence and mortality worldwide: IARC CancerBase No. 11. In: GLOBOCAN 2012. http://globocan.iarc.fr. 2012. Accessed 11/04/2015 2015. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al. Cancer incidence and mortality worldwide: IARC CancerBase No. 11. In: GLOBOCAN 2012. http://​globocan.​iarc.​fr. 2012. Accessed 11/04/2015 2015.
2.
go back to reference Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, et al. Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002;94(10):2766–92.CrossRefPubMed Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, et al. Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002;94(10):2766–92.CrossRefPubMed
6.
go back to reference Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59(3):255–63.CrossRefPubMed Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59(3):255–63.CrossRefPubMed
8.
go back to reference Balducci L, Beghe C. The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Oncol Hematol. 2000;35(3):147–54.CrossRefPubMed Balducci L, Beghe C. The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Oncol Hematol. 2000;35(3):147–54.CrossRefPubMed
12.
go back to reference Cesari M, Gambassi G, van Abellan Kan G, Vellas B. The frailty phenotype and the frailty index: different instruments for different purposes. Age Ageing. 2014;43(1):10–2.CrossRefPubMed Cesari M, Gambassi G, van Abellan Kan G, Vellas B. The frailty phenotype and the frailty index: different instruments for different purposes. Age Ageing. 2014;43(1):10–2.CrossRefPubMed
13.
go back to reference Wong R, Espinoza M, Palloni A. Mexican older adults with a wide socioeconomic perspective: health and aging. Salud Publica Mex. 2007;49 Suppl 4:S436–47.PubMed Wong R, Espinoza M, Palloni A. Mexican older adults with a wide socioeconomic perspective: health and aging. Salud Publica Mex. 2007;49 Suppl 4:S436–47.PubMed
16.
go back to reference Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci. 2007;62(7):738–43.CrossRefPubMed Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci. 2007;62(7):738–43.CrossRefPubMed
17.
go back to reference Lynch SM, George LK. Interlocking trajectories of loss-related events and depressive symptoms among elders. J Gerontol Ser B Psychol Sci Soc Sci. 2002;57:S117–25.CrossRef Lynch SM, George LK. Interlocking trajectories of loss-related events and depressive symptoms among elders. J Gerontol Ser B Psychol Sci Soc Sci. 2002;57:S117–25.CrossRef
24.
go back to reference Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med. 2002;162(20):2333–41.CrossRefPubMed Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med. 2002;162(20):2333–41.CrossRefPubMed
25.
go back to reference Oeffinger KC, Mertens AC, Hudson MM, Gurney JG, Casillas J, Chen H, et al. Health care of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Fam Med. 2004;2(1):61–70.CrossRefPubMedPubMedCentral Oeffinger KC, Mertens AC, Hudson MM, Gurney JG, Casillas J, Chen H, et al. Health care of young adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Fam Med. 2004;2(1):61–70.CrossRefPubMedPubMedCentral
26.
28.
go back to reference Ligibel JA, Denlinger CS. New NCCN guidelines for survivorship care. J Natl Compr Cancer Netw. 2013;11(5 Suppl):640–4. Ligibel JA, Denlinger CS. New NCCN guidelines for survivorship care. J Natl Compr Cancer Netw. 2013;11(5 Suppl):640–4.
29.
go back to reference Angelopoulos N, Barbounis V, Livadas S, Kaltsas D, Tolis G. Effects of estrogen deprivation due to breast cancer treatment. Endocr Relat Cancer. 2004;11(3):523–35.CrossRefPubMed Angelopoulos N, Barbounis V, Livadas S, Kaltsas D, Tolis G. Effects of estrogen deprivation due to breast cancer treatment. Endocr Relat Cancer. 2004;11(3):523–35.CrossRefPubMed
30.
Metadata
Title
Cancer and frailty in older adults: a nested case-control study of the Mexican Health and Aging Study
Authors
Mario Ulises Pérez-Zepeda
Eduardo Cárdenas-Cárdenas
Matteo Cesari
Ana Patricia Navarrete-Reyes
Luis Miguel Gutiérrez-Robledo
Publication date
01-08-2016
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 4/2016
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-016-0519-6

Other articles of this Issue 4/2016

Journal of Cancer Survivorship 4/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine